🇺🇸 FDA
Patent

US 8354450

Creatine oral supplementation using creatine hydrochloride salt

granted A61KA61K31/185A61K31/195

Quick answer

US patent 8354450 (Creatine oral supplementation using creatine hydrochloride salt) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/185, A61K31/195, A61K31/198, A61K31/661